Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | 338,795 | reported | 17 Jun 2025 | tx 3+338,795 |
| DOV PHARMACEUTICAL INC | 335,000 | reported | 28 Jun 2006 | tx 3+60,000 |
| Viridian Therapeutics, Inc.\DE | 259,500 | reported | 12 Apr 2023 | tx 4+1,259,500 |
| Trillium Therapeutics Inc. | 0 | reported | 17 Nov 2021 | tx 2+67,000−67,000 |
| Oncothyreon Inc. | 0 | reported | 09 Mar 2018 | tx 25+3,562,455−1,109,326 |
| Cartesian Therapeutics, Inc. | 0 | reported | 13 Nov 2023 | tx 13+308,049−207,500 |
| ADVANCED MAGNETICS INC | 0 | reported | 16 Nov 2020 | tx 2+1,000,000−1,000,000 |
| DYNAVAX TECHNOLOGIES CORP | 0 | reported | 10 Feb 2026 | tx 18+170,379−170,379 |
| Harpoon Therapeutics, Inc. | 0 | reported | 11 Mar 2024 | tx 15+200,573−29,298 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Feb 2026 | TENDER | DYNAVAX TECHNOLOGIES CORP | 3,800 | — | |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 31,204 | — | |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 28,500 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 22,500 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 22,500 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 45,000 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 16,875 | — | deriv |
| 22 Aug 2025 | PURCHASE | DYNAVAX TECHNOLOGIES CORP | 3,800 | 10.82 USD | |
| 17 Jun 2025 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 57,603 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 5,758 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 28,500 | 0.00 USD | deriv |
| 30 Apr 2025 | PURCHASE | Zentalis Pharmaceuticals, Inc. | 21,000 | 1.40 USD | first after silence |
| 13 Nov 2024 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 260,192 | 0.00 USD | |
| 23 May 2024 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 5,357 | 0.00 USD | |
| 23 May 2024 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 22,500 | 0.00 USD | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 22,665 | — | |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 4,600 | — | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 2,033 | — | deriv |
| 01 Jan 2024 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 2,048 | 0.00 USD | |
| 27 Nov 2023 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 5,000 | 0.00 USD | |
| 13 Nov 2023 | OTHER | Cartesian Therapeutics, Inc. | 40,000 | — | deriv |
| 13 Nov 2023 | OTHER | Cartesian Therapeutics, Inc. | 40,000 | — | deriv |
| 13 Nov 2023 | OTHER | Cartesian Therapeutics, Inc. | 20,000 | — | deriv |
| 13 Nov 2023 | OTHER | Cartesian Therapeutics, Inc. | 20,000 | — | deriv |
| 13 Nov 2023 | OTHER | Cartesian Therapeutics, Inc. | 87,500 | 0.93 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 30 Apr 2025.